Is ALGEN.PA undervalued or overvalued?
As of 2025-03-23, the Intrinsic Value of Genoway SA (ALGEN.PA) is 11.71 EUR. This ALGEN.PA valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 3.29 EUR, the upside of Genoway SA is 256.00%. This means that ALGEN.PA is undervalued by 256.00%.
The range of the Intrinsic Value is 6.11 - 81.47 EUR
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (7.33) - (1.01) | (1.48) | -144.9% |
DCF (Growth 10y) | 6.11 - 81.47 | 11.71 | 256.0% |
DCF (EBITDA 5y) | 7.17 - 8.40 | 8.13 | 147.2% |
DCF (EBITDA 10y) | 10.19 - 12.47 | 11.76 | 257.4% |
Fair Value | 3.31 - 3.31 | 3.31 | 0.68% |
P/E | 3.45 - 5.45 | 4.17 | 26.6% |
EV/EBITDA | 5.51 - 7.45 | 6.39 | 94.1% |
EPV | 0.59 - 0.76 | 0.68 | -79.4% |
DDM - Stable | 2.57 - 28.01 | 15.29 | 364.7% |
DDM - Multi | 7.41 - 62.66 | 13.24 | 302.4% |
Market Cap (mil) | 31.19 |
Beta | 0.39 |
Outstanding shares (mil) | 9.48 |
Enterprise Value (mil) | 32.70 |
Market risk premium | 5.82% |
Cost of Equity | 5.87% |
Cost of Debt | 5.00% |
WACC | 5.54% |